NEW YORK (GenomeWeb News) – WaferGen Biosystems today said that it has "established a relationship" with Integrated DNA Technologies to provide IDT's PrimeTime qPCR primers for SYBR-based gene expression assays.
Financial and other terms of the deal were not announced. WaferGen announced the deal in conjunction with the launch of its MyDesign open-format, high-throughput qPCR platform.
IDT has developed more than 800,000 SYBR-based gene expression assays using a design engine that eliminates cross reactivity and that includes SNP and intron/exon junction information, WaferGen said. It and IDT will collaboratively provide custom assay design services for formalin-fixed, paraffin-embedded-derived samples to WaferGen customers, it added.